Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes
AUTOR(ES)
Zhou, Ming
FONTE
The National Academy of Sciences
RESUMO
We have found that mutant acetylcholine receptor channels (AChRs) that cause slow-channel congenital myasthenic syndromes are activated by serum and that the high frequency of openings in serum is reduced by treatment with choline oxidase. Thus, slow-channel congenital myasthenic syndrome AChRs at the neuromuscular junction are likely to be activated both by steady exposure to serum choline and by transient exposure to synaptically released transmitter. Single-channel kinetic analyses indicate that the increased response to choline is caused by a reduced intrinsic stability of the closed channel. The results suggest that a mutation that destabilizes the inactive conformation of the AChR, together with the sustained exposure of endplates to serum choline, results in continuous channel activity that contributes to the pathophysiology of the disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17912Documentos Relacionados
- Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates.
- Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans
- Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
- Rapsyn Mutations in Humans Cause Endplate Acetylcholine-Receptor Deficiency and Myasthenic Syndrome
- Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit.